• 597 Citations
20112019
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

I am dedicated to providing the high-quality and compassionate care for patients with breast cancer. I am interested in clinical research with a focus on developing clinical trials of novel agents for the treatment of all stages of breast cancer and investigating biomarkers to guide therapy decisions.

Training Experience

2014Residency, Northwestern University, McGaw Medical Center
2018Fellowship, Northwestern University, McGaw Medical Center

Education/Academic qualification

MD, Northwestern University Feinberg School of Medicine

… → 2011

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Heart Failure Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Anthracyclines Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Registries Medicine & Life Sciences
Alveolar Rhabdomyosarcoma Medicine & Life Sciences
Hospitalization Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2019

  • 597 Citations
  • 10 Article
  • 6 Review article
  • 1 Chapter

Inhibitors of Tumor Angiogenesis

Shah, AN. & Gradishar, WJ., 2019, Cancer Chemotherapy, Immunotherapy, and Biotherapy: Principles and Practice, 6th edition. Chabner, B. & Longo, DL. (eds.). Philadelphia: Wolters Kluwer

Research output: Chapter in Book/Report/Conference proceedingChapter

Adjuvant Anthracyclines in Breast Cancer: What Is Their Role?

Shah, A. N. & Gradishar, W. J., Jan 1 2018, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Anthracyclines
Breast Neoplasms
Cyclophosphamide
Therapeutics
Lymph Nodes

Adjuvant Anthracyclines in Breast Cancer: What Is Their Role?

Shah, A. N. & Gradishar, W. J., Aug 17 2018, In : The oncologist.

Research output: Contribution to journalReview article

Anthracyclines
Breast Neoplasms
Cyclophosphamide
Therapeutics
Lymph Nodes
1 Citations

Anaplastic lymphoma kinase mutation (ALK F1174C) in small cell carcinoma of the prostate and molecular response to alectinib

Carneiro, B. A., Pamarthy, S., Shah, A. N., Sagar, V., Unno, K., Han, H. Y., Yang, X. J., Costa, R. B., Nagy, R. J., Lanman, R. B., Kuzel, T. M., Ross, J. S., Gay, L., Elvin, J. A., Ali, S. M., Cristofanilli, M., Chae, Y. K., Giles, F. J. & Abdulkadir, S. A., Jun 15 2018, In : Clinical Cancer Research. 24, 12, p. 2732-2739 8 p.

Research output: Contribution to journalArticle

Small Cell Carcinoma
Prostate
Mutation
Organoids
Prostatic Neoplasms
3 Citations

A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer

Santa-Maria, C. A., Kato, T., Park, J. H., Kiyotani, K., Rademaker, A. W., Shah, A. N., Gross, L., Blanco Jr, L. Z., Jain, S., Flaum, L. E., Tellez, C., Stein, R., Uthe, R., Gradishar, W. J., Cristofanilli, M., Nakamura, Y. & Giles, F. J., Apr 10 2018, In : Oncotarget. 9, 27, p. 18985-18996 12 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Breast Neoplasms
T-Cell Antigen Receptor
Exome
Granzymes